Treasury & Bonds
View Full List
Dow Jones Industrial Average
Standard & Poors 500
NYSE COMPOSITE INDX
Streaming Delayed Price
5:20 PM EDT, Apr 28, 2016
Add to My Watchlist
Stories about CRYO-CELL INTL
Cryo-Cell Commences Tender Offer to Purchase its Common Stock, Up to 750,000 Shares at $3.25 per Share
June 30, 2015
Industry: Human Impact Verticals
, and 3 more.
Cryo-Cell Provides Funding for Cord Blood Clinical Trial Application to Treat ALS
August 22, 2014
, and 1 more.
Top Performing Industries For November 25, 2013
November 25, 2013
At 10:20 am, the Dow gained 0.16% to 16,090.26, the broader Standard & Poor's 500 index moved up 0.04% to 1,805.49 and the NASDAQ composite index rose 0.03% to 3,992.99. The industries that are driving...
, and 10 more.
Thursday 4/11 Insider Buying Report: ARCP, CCEL
April 11, 2013
Bargain hunters are wise to pay careful attention to insider buying, because although there are many various reasons for an insider to sell a stock, presumably the only reason they would use their...
Market News Video
Thursday 1/10 Insider Buying Report: CCEL, AXAS
January 10, 2013
As the saying goes, there are many possible reasons for an insider to sell a stock, but only one reason to buy -- they expect to make money. So let's look at two noteworthy recent insider buys.
Market News Video
More board elections mean easier targets for Icahn
August 23, 2011
Years of efforts by labor-backed pension funds and other types of money managers have driven the majority of big American companies to have their directors elected annually, a situation that experts...
, and 33 more.
Regeneron, Cephalon boost biotech stocks
May 02, 2011
Regeneron and Cephalon are the top gainers in early trading of drug stocks Monday.
, and 19 more.
The Week in Review: The Business of China Life Science
August 15, 2009
Cheezheng Tibetan Medicine was approved to IPO on the Shenzhen exchange; Shanghai Fosun Pharma now owns 24% of Tongjitang Chinese Medicines; China Aoxing Pharma raised $5 million by selling shares;...
S-Evans Biosciences Obtains China Rights for Stem Cell Technology
August 13, 2009
S-Evans Biosciences (SEB) of Hangzhou has received an exclusive license to market and manufacture the C'elle menstrual stem cell technology developed by Cryo-Cell. The rights, which are good throughout...
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Terms and Conditions
Press Release Service
provided by PRConnect.
Stock quotes supplied by Six Financial
Bots go here